Home
Scholarly Works
PCN194 Evidence Driven Cancer Drug Approvals In...
Conference

PCN194 Evidence Driven Cancer Drug Approvals In Phase II Versus Phase III Clinical Trials Within A Single-Payer Public Healthcare System

Authors

Wang Y; Ellis P

Volume

21

Publisher

Elsevier

Publication Date

May 1, 2018

DOI

10.1016/j.jval.2018.04.241

Conference proceedings

Value in Health

ISSN

1098-3015

Contact the Experts team